Pfizer Inc.
NYSE:PFE
Sector
Location
Market Cap
USD 140.72 B
Share Price
USD 23.93
Avg Daily Volume
42,669,952
Change (1 day)
-3.31%
Change (1 year)
-18.38%
Change (YTD)
-9.80%
Pfizer Inc. Accounts Payable for the year ending December 31, 2024: USD 5.63 B
Pfizer Inc. Accounts Payable is USD 5.63 B for the year ending December 31, 2024, a -16.05% change year over year. Accounts payable are amounts owed by the company to suppliers or vendors for goods or services received but not yet paid.
-
Pfizer Inc. Accounts Payable for the year ending December 31, 2023 was USD 6.71 B, a -1.45% change year over year.
-
Pfizer Inc. Accounts Payable for the year ending December 31, 2022 was USD 6.81 B, a 22.07% change year over year.
-
Pfizer Inc. Accounts Payable for the year ending December 31, 2021 was USD 5.58 B, a 30.24% change year over year.
-
Pfizer Inc. Accounts Payable for the year ending December 31, 2020 was USD 4.28 B, a 10.19% change year over year.
StockViz
Competitors
Eli Lilly and Company
USD 746.37
LLY
-19.58
-2.56%
AbbVie Inc.
USD 196.30
ABBV
-2.25
-1.13%
Roche Holding AG
USD 322.52
RO.SW
-10.06
-3.03%
AstraZeneca PLC
USD 150.15
AZN.L
-2.01
-1.32%
Novartis AG
USD 114.49
NOVN.SW
-3.72
-3.15%
Novo Nordisk A/S
USD 45.10
NOVO-B.CO
-2.22
-4.69%
Merck & Co., Inc.
USD 79.44
MRK
-1.35
-1.67%
Thermo Fisher Scientific Inc.
USD 448.94
TMO
-17.48
-3.75%
Amgen Inc.
USD 284.67
AMGN
-15.41
-5.13%
Gilead Sciences, Inc.
USD 110.28
GILD
-2.18
-1.94%
Sanofi
USD 92.89
SAN.PA
-2.06
-2.17%
Vertex Pharmaceuticals Incorporated
USD 385.65
VRTX
+10.67
2.84%
Bristol-Myers Squibb Company
USD 44.82
BMY
-1.03
-2.25%
Chugai Pharmaceutical Co., Ltd.
USD 49.92
4519.T
-0.37
-0.73%
Regeneron Pharmaceuticals, Inc.
USD 555.13
REGN
-14.77
-2.59%
Key Data
| Date | Accounts Payable | Short-Term Debt | Long-Term Debt | Total Liabilities |
|---|
Competitors
Eli Lilly and Company
USD 746.37
LLY
-19.58
-2.56%
AbbVie Inc.
USD 196.30
ABBV
-2.25
-1.13%
Roche Holding AG
USD 322.52
RO.SW
-10.06
-3.03%
AstraZeneca PLC
USD 150.15
AZN.L
-2.01
-1.32%
Novartis AG
USD 114.49
NOVN.SW
-3.72
-3.15%
Novo Nordisk A/S
USD 45.10
NOVO-B.CO
-2.22
-4.69%
Merck & Co., Inc.
USD 79.44
MRK
-1.35
-1.67%
Thermo Fisher Scientific Inc.
USD 448.94
TMO
-17.48
-3.75%
Amgen Inc.
USD 284.67
AMGN
-15.41
-5.13%
Gilead Sciences, Inc.
USD 110.28
GILD
-2.18
-1.94%
Sanofi
USD 92.89
SAN.PA
-2.06
-2.17%
Vertex Pharmaceuticals Incorporated
USD 385.65
VRTX
+10.67
2.84%
Bristol-Myers Squibb Company
USD 44.82
BMY
-1.03
-2.25%
Chugai Pharmaceutical Co., Ltd.
USD 49.92
4519.T
-0.37
-0.73%
Regeneron Pharmaceuticals, Inc.
USD 555.13
REGN
-14.77
-2.59%